Overview


According to FutureWise analysis, the market for Plasma Expander is expected to grow with a CAGR of 6.92% over the forecast period 2024-2032, and reach a market value of US$ 48.3 Billion by 2031. 

Plasma expanders are a crucial component of medical treatment designed to restore or maintain blood volume and circulation when a patient's blood volume is insufficient. They serve as substitutes for whole blood or blood components when immediate access to these resources is limited or not feasible. These solutions are typically administered intravenously and are composed of various substances, including colloid-based solutions like starches, gelatins, or albumin, as well as crystalloid-based solutions like saline or Ringer's lactate.

Plasma expanders are critical in numerous medical situations, including surgical procedures, trauma care, and acute care settings. During surgery, they help maintain blood pressure and perfusion to vital organs, enabling surgeons to work effectively. In trauma cases, where rapid blood loss can be life-threatening, plasma expanders provide immediate support until blood products are available. In intensive care units, they are used to stabilize patients and support their recovery. Plasma expanders are valuable tools in emergency and surgical medicine; they are not a replacement for whole blood or specific blood components in all clinical scenarios. Each has its indications, contraindications, and potential risks, and their administration is guided by a physician's assessment of the patient's specific needs.

FutureWise Market Research has published a report that provides an insightful analysis of Plasma Expander Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Plasma Expander Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • CSL Limited
  • Grifols, S.A.
  • B. Braun Melsungen AG
  • Hikma Pharmaceuticals PLC
  • Octapharma AG
  • Kedrion S.p.A.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Terumo Corporation
  • JW Life Science
  • Celgene Corporation
  • Pentapharm Ltd.
  • Haemonetics Corporation
  • Macopharma

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Plasma Expander Market:

  • In 2022, Kedrion SpA finalized the acquisition of Haemaccel, a plasma-based expander, from CSL Behring. This strategic move marked a significant development in Kedrion's portfolio, enhancing its capabilities in plasma-based therapies.
  • Similarly, in 2021, Grifols acquired Dextran 70, another notable plasma-based expander, from Octapharma. This acquisition bolstered Grifols' position in the global plasma-derived product market and expanded its offerings in critical medical solutions.

The global surge in elective and emergency surgical procedures is a significant driver for the plasma expander market. These expanders are pivotal for maintaining adequate blood volume and pressure during surgeries, ensuring optimal conditions for surgeons and safe patient recovery, and driving the market. The escalating incidence of trauma cases, including accidents, injuries, and major disasters, necessitates immediate medical attention. Plasma expanders are critical in revitalizing and stabilizing patients in acute conditions, especially before whole blood or blood components become available. This steady rise in trauma cases globally is expected to sustain demand for plasma expanders, particularly in emergency departments and trauma centers. The world's aging population is leading to a higher prevalence of age-related conditions and surgical interventions. Elderly patients often require surgeries, and plasma expanders are instrumental in maintaining hemodynamic stability during these procedures. The demographic shift towards an older population is anticipated to be a significant driver for the plasma expander market, with a continued uptick in demand for these products.

However, some patients may experience adverse reactions to plasma expanders, including allergic reactions, hemolysis, or volume overload, and can limit the use of certain types of plasma expanders in specific patient populations and restrict the use of plasma expanders, impacting market growth. The plasma expander market is subject to rigorous regulatory scrutiny to ensure product safety, efficacy, and quality, which is often time-consuming and potentially slows the introduction of new products and innovations into the market.

By Product Type

  • Colloids
  • Crystalloids

By Source

  • Human Plasma-derived Expanders
  • Synthetic Expanders
  • Others (e.g., animal-derived expanders)

By Application

  • Trauma and Surgical Procedures
  • Burn Management
  • Hypovolemia
  • Sports Medicine
  • Others

By Distribution Channel

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Online Retail
  • Others

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the high prevalence of chronic diseases and trauma in the region and the presence of many key players in the market. Conversely, the European region is poised for substantial expansion in the forecast period due to the increasing demand for plasma expanders in the critical care setting and the rising prevalence of cardiovascular diseases in the region. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Plasma Expander Market By Product Type, By Source, By Application, By Distribution Channel and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Plasma Expander Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Plasma Expander Market Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Plasma Expander Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Plasma Expander Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Colloids
        2. Crystalloids

  • 8.  Plasma Expander Market, By Source Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Human Plasma-derived Expanders
        2. Synthetic Expanders
        3. Others (e.g., animal-derived expanders)

  • 9.  Plasma Expander Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Trauma and Surgical Procedures
        2. Burn Management
        3. Hypovolemia
        4. Sports Medicine
        5. Others

  • 10.  Plasma Expander Market, By Distribution Channel Historical Analysis and Forecast 2024-2032 (USD Million)

    • 1. Hospitals and Clinics
      2. Ambulatory Surgical Centers
      3. Online Retail
      4. Others

  • 11.  North America Plasma Expander Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Plasma Expander Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Plasma Expander Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Plasma Expander Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Baxter International Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Fresenius SE & Co. KGaA
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. CSL Limited
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Grifols, S.A.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. B. Braun Melsungen AG
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Hikma Pharmaceuticals PLC
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Octapharma AG
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Kedrion S.p.A.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Shanghai RAAS Blood Products Co., Ltd.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Terumo Corporation
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. JW Life Science
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Celgene Corporation
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Pentapharm Ltd.
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Haemonetics Corporation
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Macopharma
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11